Effect of statin versus fibrate on postprandial endothelial dysfunction: Role of remnant-like particles

Cardiovascular Research

Volumn 50, Issue 3, 2001, Pages 577-582

  Wilmink, Hanneke W ^a   Twickler, Marcel B ^a   Banga, Jan Dirk ^a   Dallinga Thie, Geesje M ^a   Eeltink, Hans ^b   Erkelens, D Willem ^a   Rabelink, Ton J ^a   Stroes, Erik S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Bayer Netherlands   (Netherlands)

Author keywords

Endothelial function; Statins; Vasoconstriction dilation

Indexed keywords

CERIVASTATIN; CHOLESTEROL; GEMFIBROZIL; GLYCERYL TRINITRATE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BODY FAT; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ENDOTHELIUM LESION; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

ADOLESCENT; ADULT; ANTILIPEMIC AGENTS; CROSS-OVER STUDIES; DIETARY FATS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; POSTPRANDIAL PERIOD; PYRIDINES; VASODILATION;

EID: 0035017489     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00227-9     Document Type: Article

References (29)

1. Cohn J.S., Marcoux C., Davignon J. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol. 19:1999;2474-2486.
2. Doi H., Kugiyama K., Ohgushi M., et al. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscler Thromb Vasc Biol. 19:1999;1918-1924.
3. Inoue T., Saniabadi A.R., Matsunaga R., Hoshi K., Yaguchi I., Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis. 139:1998;363-367.
4. Chung B.H., Hennig B., Cho B.H., Darnell B.E. Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma. Atherosclerosis. 141:1998;321-332.
5. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 101:2000;1899-1906.
6. Doi H., Kugiyama K., Ohgushi M., et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 137:1998;341-349.
7. Kugiyama K., Doi H., Motoyama T., et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 97:1998;2519-2526.
8. Wilmink H.W., Banga J.D., Hijmering M., Erkelens W.D., Stroes E.S., Rabelink T.J. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function. J Am Coll Cardiol. 34:1999;140-145.
9. Wilmink H.W., Stroes E.S., Erkelens W.D., et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol. 20:2000;185-188.
10. Vogel R.A., Corretti M., Plotnick G.D. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 79:1997;350-354.
11. Twickler Th.B., Dallinga-Thie G.M., de Valk H.W., et al. High dose of simvastatin normalizes postprandial remnant-like-particle response in patients with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 20:2000;2422-2427.
12. Schreuder PCNJ, Twickler ThB, Wang T, Nakajima K, Erkelens DW, Dallinga-Thie GM. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects. Atherosclerosis (in press).
13. Castro Cabezas M., de Bruin T.W., Westerveld H.E., Meijer E., Erkelens W. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. J Intern Med. 244:1998;299-307.
14. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 33:1992;369-380.
15. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum monoclonal anti-Apo B-100 and anti Apo-AI immunoaffinity mixed gels. Clin Chem Acta. 223:1993;53-71.
16. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 343:1994;1199-1206.
17. Schroeder S., Enderle M.D., Ossen R., et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J. 138:1999;731-739.
18. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
19. Cohn J.S. Postprandial lipid metabolism. Curr Opin Lipidol. 5:1994;185-190.
20. Schnell G.B., Robertson A., Houston D., Malley L., Anderson T.J. Impaired brachial artery endothelial function is not predicted by elevated triglycerides. J Am Coll Cardiol. 33:1999;2038-2043.
21. Steinberg H.O., Tarshoby M., Monestel R., Hook G., Cronin J., Johnson A., Bayazeed B., Baron A.D. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 100:1997;1230-1239.
22. Kugiyama K., Motoyama T., Doi H., et al. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels. J Am Coll Cardiol. 33:1999;1512-1518.
23. Ginsberg H.N. Effects of statins on triglyceride metabolism. Am J Cardiol. 81:1998;32B-35B.
24. Chung B.H., Hennig B., Cho B.H., Darnell B.E. Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma. Atherosclerosis. 141:1998;321-332.
25. Williams C.M. Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis. 141:(Suppl 1):1998;S87-S92.
26. Watts G.F., Dimmitt S.B. Fibrates, dyslipoproteineamia and cardiovascular disease. Curr Opin Lipidol. 10:1999;561-574.
27. Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than just lower cholesterol. Lancet. 348:1996;1079-1082.
28. John S., Schlaich M., Langenfeld M., et al. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation. 98:1998;211-216.
29. Laufs U., La F.V., Plutzky J., Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 97:1998;1129-1135.